| Literature DB >> 21590396 |
Edwige Dormond1, Amine A Kamen.
Abstract
Adenoviral vector (AdV) of the third generation also known as helper-dependent adenoviral vector (HDV) is an attractive delivery system for gene therapy applications. However, obtaining high quality-grade HDV in sufficient amount remains a challenge that hampers the extensive use of this vector in preclinical and clinical studies. Here we review recent progress in the large-scale manufacturing of HDV. The production of HDV is now amenable to large-scale volume with reduced process duration under optimized rescue and co-infection conditions. Also, efficient downstream processing of HDV with acceptable recovery of HDV and minimal contamination by the helper virus is described.Mesh:
Year: 2011 PMID: 21590396 DOI: 10.1007/978-1-61779-095-9_6
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745